The increasing demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using diverse expression systems, including prokaryotic hosts, animal cell populations, and in